Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer
- Grunt, T.W.
- Slany, A.
- Semkova, M.
- Colomer, R.
- López-Rodríguez, M.L.
- Wuczkowski, M.
- Wagner, R.
- Gerner, C.
- Stübiger, G.
Revue:
Scientific Reports
ISSN: 2045-2322
Année de publication: 2020
Volumen: 10
Número: 1
Type: Article
